ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Marquis Who's Who Honors James Eyerman, MD, as a Top Doctor

UNIONDALE, NY / ACCESS Newswire / September 9, 2025 / Marquis Who's Who honors James Eyerman, MD, as a top doctor for his expertise in psychiatric health care. As a distinguished psychiatrist and breathwork practitioner, Dr. Eyerman explores a wide range of nontraditional therapeutic methods to achieve better outcomes for his patients. Through his work, he asserts that there are effective alternatives to traditional therapy.

Before beginning his professional career, Dr. Eyerman established an academic foundation. He earned a medical degree from St. Louis University School of Medicine in 1974 and completed a residency in psychiatry at Washington University in 1978. Additionally, he was board-certified in psychiatry and neurology through the American Board of Psychiatry and Neurology in 1980. Furthermore, Dr. Eyerman is trained as a transcendental meditation teacher and has studied with prominent spiritual leaders, including the Dalai Lama, Maharishi Mahesh Yogi, Sri Sri Ravi Shankar and Sri Ma. He has also been a long-term student of Stanislav Grof, considered the ‘godfather of LSD psychotherapy.

Dr. Eyerman's Professional Career

Following his studies, Dr. Eyerman served as the medical director of Epworth Children's Home in St. Louis, Missouri, a position he held until 2001. In 1989, he was appointed medical director of Maharishi Ayurveda Medical Center and director of the Transpersonal Institute of San Francisco, a role he still holds today. After two years there, he joined the Masters and Johnson Institute as director of its sexual trauma, PTSD and stress programs.

In 1999, Dr. Eyerman became a psychiatric consultant at St. Louis University's department of child neurology. Two years later, he became a self-employed practitioner of psychopharmacology, holotropic breathwork and Ayurvedic medicine. The next year, he also became a psychiatrist at La Cheim Inc. and, in 2008, entered a staff position at Napa State Hospital. Within each of these experiences and ongoing roles, Dr. Eyerman has refined an integrative approach to using psychopharmacology.

Among Dr. Eyerman's most notable achievements is his involvement in conducting a study with 11,000 psychiatric patients at St. Anthony's Medical Center in St. Louis. There, he employed holotropic breathwork techniques with zero adverse reactions or complaints. Additionally, he helped pioneer the use of eye-movement desensitization and reprocessing (EMDR) from 1989 to 1990. Dr. Eyerman's contributions to psychiatry have been formally recognized through his designation as a Distinguished Life Fellow by the American Psychiatric Association in 2016.

Civic and Membership Involvement

Outside of his professional career, Dr. Eyerman is involved in several civic and membership organizations. He is a part of the Transcendental Meditation Ferusha Group, the Syda Yoha Groups and is a consultant for St. Michael's Catholic Church rehab programs. Furthermore, he is a member of the Spirituality and Psychiatry Section of the American Psychiatric Association and the Association of Holotropic Breathwork International, as well as the president of the North Bay Chapter of the Northern California Psychiatric Society.

Published Contributions to the Health Care Industry

Creatively, Dr. Eyerman has written several research papers on subjects ranging from holotropic breathwork to transcendental meditation. Most recently, he wrote six research papers, including "Holotropic Breathwork: Models of Mechanism in Action" in the Journal of Transpersonal Research in 2014, as well as "Magdalenian Grottes, Kalahari San People and a Contemporary Integrative Psychiatric Approach" in the Northern California Psychiatric Society Newsletter in 2013.

Plans for the Future

Within the next five years, Dr. Eyerman plans to develop his integrative psychiatric practice by focusing on incorporating psychedelics beyond his current use of ketamine and holotropic breathwork. Additionally, he hopes to explore alternative treatment methods, such as creative arts therapy, trance and dance. In the near future, he looks forward to presenting at the European Transpersonal Association Symposium in Oaxaca, Mexico, in October 2025.

About Marquis Who's Who®:

Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms worldwide. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

Marquis Who's Who
Uniondale, NY
(844) 394 - 6946
info@marquiswhoswho.com
www.marquiswhoswho.com

SOURCE: Marquis Who's Who



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.